U.S. Oil and Gas Stock News

NasdaqGS:EGHT
NasdaqGS:EGHTSoftware

8x8 (EGHT): Loss Reduction Continues, but Persistent Unprofitability Challenges Value Narrative

8x8 (EGHT) remains unprofitable, but over the past five years, the company has steadily reduced its losses by 34.4% per year. Its valuation stands out in the crowded software space, trading at a Price-To-Sales Ratio of just 0.4x. This figure is significantly below both the peer average of 15.9x and the US software industry average of 5.1x. While this low multiple may attract value-oriented investors, the share price has displayed notable volatility recently, and the lack of accelerating...
NasdaqGS:BRY
NasdaqGS:BRYOil and Gas

Berry (BRY): One-Off $3.9M Loss Challenges Bull Case on Margin-Led Growth

Berry (BRY) has become profitable over the past five years, reporting an average earnings growth of 41.6% per year. Looking ahead, earnings are expected to surge another 159.2% annually, but revenue is forecast to decline at an average pace of -1.1% per year for the next three years. The company also recorded a one-off loss of $3.9 million in the most recent financial year, tempering the near-term earnings outlook. Investors will be weighing this mix of rapid projected earnings growth and...
NasdaqGM:AVDL
NasdaqGM:AVDLPharmaceuticals

Avadel Pharmaceuticals (AVDL): Revenue Forecast to Grow 15.6% Annually Heading Into Earnings Season

Avadel Pharmaceuticals (AVDL) continues to operate at a loss, with losses having grown at an average annual rate of 12.4% over the past five years and a net profit margin that remains unimproved year over year. Despite its current lack of profitability, Avadel’s revenue is forecast to climb 15.6% annually, which is ahead of the broader US market’s 10.5%. Earnings are projected to surge by 40.12% each year. The company is anticipated to reach profitability within three years, and with its...
NasdaqGS:CNTA
NasdaqGS:CNTABiotechs

Centessa Pharmaceuticals (CNTA): Rapid 74.3% Revenue Growth Challenges Profitability Concerns

Centessa Pharmaceuticals (CNTA) is forecast to deliver stellar annual revenue growth of 74.3%, far surpassing the broader US market’s 10.5% pace. Despite the robust top-line outlook, the company remains unprofitable and is expected to continue operating at a loss over the next three years. While losses have narrowed at an average rate of 4.3% per year over the past five years, there are no signs of an imminent shift toward profitability. This raises the stakes for investors weighing rapid...
NYSE:MRC
NYSE:MRCTrade Distributors

MRC Global (MRC) Net Margin Decline Raises Questions on Premium Valuation and Turnaround Narrative

MRC Global (MRC) has delivered a notable turnaround, with earnings climbing at an annual rate of 76% over the past five years and forecasts pointing to ongoing 20% per year growth, well above the broader US market’s 16% outlook. Despite the positive trajectory, revenue growth is expected to trail at 3.9% per year compared to a 10.5% pace for the US market, and net profit margins recently slipped from 2.7% to 1.1%. The stock’s price-to-earnings ratio sits at 36.6x, considerably above peers and...
NasdaqGS:ODP
NasdaqGS:ODPSpecialty Retail

ODP (ODP) Net Margin Falls to 0.7%: One-Off Loss Challenges Bull Case

ODP (ODP) reported a net profit margin of 0.7%, down from 2% a year ago, as a one-off loss of $107.0 million weighed on performance over the last twelve months. While the company has averaged 12.3% annual earnings growth since turning profitable, upcoming years are expected to bring a 2.5% annual revenue decline. Investors now face a mixed picture, with ongoing margin pressure and the recent one-off loss on one side, but relative value compared to peers providing a potential bright spot. See...
NasdaqCM:AEYE
NasdaqCM:AEYESoftware

AudioEye (AEYE) Trades Below Fair Value, Revenue Outlook Tops Market Narratives

AudioEye (AEYE) remains unprofitable but has steadily narrowed its losses over the last five years at an annual rate of 18.4%. Revenue is now forecast to grow 11.5% per year, topping the US market average of 10.5%, even as net profit margins are yet to turn positive. Investors weighing the numbers will note that the company is valued at a 4.7x Price-to-Sales ratio and currently trades at $14.43, below the estimated fair value of $16.72. This keeps the spotlight on its growth prospects and...
NYSE:WOW
NYSE:WOWMedia

WOW (WideOpenWest): Losses Worsen, Profitability Outlook Challenges Bull Case

WideOpenWest (WOW) remains in the red, showing no recent progress in improving its profit margins. Over the last five years, losses have worsened at an annual rate of 12.7%. Consensus expects revenue to decline 2.8% per year over the next three years. With forecasts pointing to continued unprofitability, investors face a story of persistent losses and declining top-line numbers in the coming years. See our full analysis for WideOpenWest. Next, we will compare these headline numbers with the...
NYSE:ACA
NYSE:ACAConstruction

Assessing Arcosa’s Value After 7% Stock Jump Driven by Infrastructure Bill News

Wondering if Arcosa's current share price is a steal or too good to be true? You are not alone in wanting to get to the bottom of its real value. In just the last week, Arcosa's stock climbed 7.1%, adding to an 8.6% gain over the past month and bringing its five-year return to an impressive 86.6%. Much of this momentum follows recent headlines about new infrastructure spending bills and Arcosa's strategic position to benefit from heightened demand in the construction industry. Investors are...
NYSE:SPG
NYSE:SPGRetail REITs

Simon Property Group (SPG): Net Margin Declines to 36.4%, Challenging Bullish Valuation Narratives

Simon Property Group (SPG) reported a net profit margin of 36.4%, a notable decrease from last year's 41.4%. Earnings have grown at an annual rate of 9.7% over the past five years. Despite high earnings quality, growth is projected to slow as revenue is forecast to rise by just 1.8% per year and EPS by 3.39% per year, both trailing the US market averages. Investors are weighing a muted growth outlook and margin compression against the fact that shares trade below one estimate of fair value...
NasdaqGS:CCSI
NasdaqGS:CCSISoftware

Consensus Cloud Solutions (CCSI): Exploring Valuation Ahead of Q3 2025 Earnings and Upgraded Analyst Forecasts

Consensus Cloud Solutions (CCSI) is drawing increased attention ahead of its upcoming Q3 2025 earnings release, as recent updates to revenue and earnings estimates have sparked renewed interest among investors. See our latest analysis for Consensus Cloud Solutions. Consensus Cloud Solutions’ share price has surged 42.6% in the past 90 days, while its 1-year total shareholder return stands at 22.3%. The momentum suggests building optimism ahead of earnings, even as the stock continues to...
NasdaqGS:GOGO
NasdaqGS:GOGOWireless Telecom

Could Gogo’s (GOGO) 5G Test Progress Hint at a New Era of Competitive Advantage?

Gogo has begun in-flight testing of its next-generation 5G air-to-ground connectivity network for North American customers, marking a significant step toward commercial rollout before the end of 2025 and following validation of key hardware and software. An interesting detail is that 400 aircraft have already been pre-provisioned for the new 5G service, up from 300 in the last three months, highlighting growing client anticipation ahead of full activation and expected service-driven revenue...
NYSE:KW
NYSE:KWReal Estate

Kennedy-Wilson Stock Drops 25% in 2024 Amid Real Estate Volatility, Is Opportunity Emerging?

Wondering if Kennedy-Wilson Holdings is now a value play or if there is more trouble ahead? Let’s dive in and see whether curiosity is rewarded. The stock has tumbled in 2024, dropping 24.7% year-to-date and losing over 28% across the last twelve months as investor sentiment has shifted quickly. Recent headlines have centered on industry-wide volatility in real estate, with rising interest rates and macro uncertainty putting pressure on REITs and property holding firms like Kennedy-Wilson...